Since pancreatobiliary diversion probably stimulates pancreatic growth by increasing cholecystokinin secretion, the effect of the cholecystokinin antagonist CR-1409 on this adaptive response was tested. Male Wistar rats (n=108) weighing 220-250g were randomised to receive either pancreatobiliary diversion (n=60) or sham diversion (n=48) and thereafter to receive either saline injections or CR-1409 (10 mg/kg/day, subcutaneously 
p<O0OOl). Pancreatobiliary diversion increased bromodeoxyuridine labelling index from 1 1 to 3*7% at seven days and the cell birth rate from 0*09 to 0*06%. CR Accepted for publication 4 October 1990 Experimental diversion of bile and pancreatic secretions to the mid-small bowel in rats causes both intestinal and pancreatic growth, ' tracer labelled with iodine-125 (1000 cpm, Amersham, UK) in 0 05 mol/l sodium phosphate buffer (pH 7 4) with 0-25% gelatin and 0-01 mol/l EDTA. Free and bound tracer were separated by the addition of 6% (weight/volume) charcoal (Norit PN5, BDH, Poole, UK) with 0-6% (weight/volume) dextran. The concentrations of pure peptides that produced half maximum inhibition of binding of tracer to A2 were 2-0 pmol/l for cholecystokinin 8, 2-4 pmol/l for cholecystokinin 33, and 2-2 nmol/l for gastrin 17. The coefficient of variation within assays was 8-2% and between assays was 12-8%. The sensi- (Fig 1) There were nine early deaths from anastomotic leakage (pancreatobiliary diversion 7, transection 2). There was no significant difference in body weight between the groups at four days. At seven days, rats with pancreatobiliary diversion plus CR-1409 weighed 17% less than controls (triple transection+saline). By --e---PBD+CR-1409 had no effect in rats with sham pancreatobiliary 4-T diversion. 
Results
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Discussion
Our data support a tropic role for cholecystokinin in pancreatic growth after pancreatobiliry diversion,4 since the operation doubled circulating concentrations of the hormone. There are two possible explanations for this hypercholecystokininaemia. Diversion of pancreatobiliary secretions from the transposed jejunum should suppress the negative feedback mechanism on cholecystokinin secretion, and the jejunal hyperplasia that follows the procedure'3 might well involve the enteroendocrine cells and lead 
